PM congratulates scientists on progress of Covid19 vaccine at Bharat Biotech

▴ PM congratulates scientists on progress of Covid19 vaccine at Bharat Biotech
After his brief visit to the Bharat Biotech in Hyderabad, he congratulated the scientists’ team for their progress in the trials so far.

Prime Minister Narendra Modi has been briefed about the indigenous COVID-19 vaccine at the Bharat Biotech facility in Hyderabad. After his brief visit to the Bharat Biotech in Hyderabad, he congratulated the scientists’ team for their progress in the trials so far.

In a message, the PM said the Bharat Biotech team is closely working with ICMR to facilitate speedy progress. He left for Pune later.
 


Earlier, he visited the vaccine development and manufacturing laboratories of Bharat Biotech and interacted with senior scientists and others. He has been briefed about the progress made so far relating to the manufacturing of the COVID-19 vaccine, called Covaxin. It may be recalled that the BBIL has taken up the manufacturing of the vaccine in collaboration with the Indian Council of Medical Research (ICMR).

The SARS-CoV-2 strain for the indigenous COVID-19 vaccine candidate was isolated in the Pune Based ICMR- National Institute of Virology and transferred to BBIL. Currently, the phase-III clinical trials of the Covaxin are underway by involving over 25 thousand volunteers in 22 states across the country.

Earlier, Prime Minister Narendra Modi arrived at Hakimpet Air Force Station near Hyderabad on his second leg of a 3-city visit this afternoon. He has been welcomed by State Chief Secretory Somesh Kumar, State DGP Mahender Reddy Medchal Malkajgiri Collector Swetha Mohanthy among other senior officials. 

Tags : #India #PrimeMinister #NarendraModi #BharatBiotech #ICMR #Scientists #Covaxin #ClinicalTrail #SARSCoV-2 #BBIL #Covid19 #Covid19Vaccine #FightAgainstCovid19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024
Empowering Patients: The Role of Advocacy in Indian HealthcareMarch 26, 2024
A New Dawn in Heart Surgery: Mitral Valve Repair for 15-Year-Old PatientMarch 26, 2024